These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34865569)

  • 21. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
    Lomelino C; McKenna R
    Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
    Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival.
    Genah S; Angeli A; Supuran CT; Morbidelli L
    Pharmacol Res; 2020 Sep; 159():104964. PubMed ID: 32485281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells.
    Grandane A; Tanc M; Di Cesare Mannelli L; Carta F; Ghelardini C; Žalubovskis R; Supuran CT
    J Med Chem; 2015 May; 58(9):3975-83. PubMed ID: 25875209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors.
    Supuran CT
    Metabolites; 2017 Sep; 7(3):. PubMed ID: 28926956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
    Bozdag M; Carta F; Ceruso M; Ferraroni M; McDonald PC; Dedhar S; Supuran CT
    J Med Chem; 2018 Jul; 61(14):6328-6338. PubMed ID: 29962205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness.
    Ciccone V; Filippelli A; Angeli A; Supuran CT; Morbidelli L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX.
    Eldehna WM; Abo-Ashour MF; Berrino E; Vullo D; Ghabbour HA; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Alharbi A; Abdel-Aziz HA; Supuran CT
    Bioorg Chem; 2019 Mar; 83():549-558. PubMed ID: 30471577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
    Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
    Ozensoy Guler O; Arslan O; Kockar F
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
    Supuran CT; Winum JY
    Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.
    Abdel Gawad NM; Amin NH; Elsaadi MT; Mohamed FMM; Angeli A; De Luca V; Capasso C; Supuran CT
    Bioorg Med Chem; 2016 Jul; 24(13):3043-3051. PubMed ID: 27234893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
    J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated carbonic anhydrases and their inhibition.
    Pastorekova S; Zatovicova M; Pastorek J
    Curr Pharm Des; 2008; 14(7):685-98. PubMed ID: 18336315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
    Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions.
    Chen F; Licarete E; Wu X; Petrusca D; Maguire C; Jacobsen M; Colter A; Sandusky GE; Czader M; Capitano ML; Ropa JP; Boswell HS; Carta F; Supuran CT; Parkin B; Fishel ML; Konig H
    J Cell Mol Med; 2021 Dec; 25(24):11039-11052. PubMed ID: 34791807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.